A new era in the treatment of primary pulmonary hypertension

被引：9

作者：

Bailey, CL ^{[1
]}

Channick, RN ^{[1
]}

Rubin, LJ ^{[1
]}

机构：

[1] Univ Calif San Diego, La Jolla, CA 92037 USA

来源：

HEART | 2001年 / 85卷 / 03期

关键词：

D O I：

10.1136/heart.85.3.251

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：251 / 252

页数：2

共 18 条

[1] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].

Badesch, DB ;

Tapson, VF ;

McGoon, MD ;

Brundage, BH ;

Rubin, LJ ;

Wigley, FM ;

Rich, S ;

Barst, RJ ;

Barrett, PS ;

Kral, KM ;

Jöbsis, MM ;

Loyd, JE ;

Murali, S ;

Frost, A ;

Girgis, R ;

Bourge, RC ;

Ralph, DD ;

Elliott, CG ;

Hill, NS ;

Langleben, D ;

Schilz, RJ ;

McLaughlin, VV ;

Robbins, IM ;

Groves, BM ;

Shapiro, S ;

Medsger, TA ;

Gaine, SP ;

Horn, E ;

Decker, JC ;

Knobil, K .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+

[2] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[3] Cell-based gene transfer to the pulmonary vasculature - Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension [J].

Campbell, AIM ;

Kuliszewski, MA ;

Stewart, DJ .

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 21 (05) :567-575

[4] Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension - An ambulatory delivery system and initial clinical tests [J].

Channick, RN ;

Newhart, JW ;

Johnson, FW ;

Williams, PJ ;

Auger, WR ;

Fedullo, PF ;

Moser, KM .

CHEST, 1996, 109 (06) :1545-1549

[5]

Channick RN, 2000, CIRCULATION, V102, P100

[6] AN IMBALANCE BETWEEN THE EXCRETION OF THROMBOXANE AND PROSTACYCLIN METABOLITES IN PULMONARY-HYPERTENSION [J].

CHRISTMAN, BW ;

MCPHERSON, CD ;

NEWMAN, JH ;

KING, GA ;

BERNARD, GR ;

GROVES, BM ;

LOYD, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :70-75

[7] Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor [J].

Cowan, KN ;

Heilbut, A ;

Humpl, T ;

Lam, C ;

Ito, S ;

Rabinovitch, M .

NATURE MEDICINE, 2000, 6 (06) :698-702

[8] SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY [J].

DALONZO, GE ;

BARST, RJ ;

AYRES, SM ;

BERGOFSKY, EH ;

BRUNDAGE, BH ;

DETRE, KM ;

FISHMAN, AP ;

GOLDRING, RM ;

GROVES, BM ;

KERNIS, JT ;

LEVY, PS ;

PIETRA, GG ;

REID, LM ;

REEVES, JT ;

RICH, S ;

VREIM, CE ;

WILLIAMS, GW ;

WU, M .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :343-349

[9] Pulmonary prostacyclin, synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension [J].

Geraci, MW ;

Gao, BF ;

Shepherd, DC ;

Moore, MD ;

Westcott, JY ;

Fagan, KA ;

Alger, LA ;

Tuder, RM ;

Voelkel, NF .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) :1509-1515

[10] EXPRESSION OF ENDOTHELIN-1 IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION [J].

GIAID, A ;

YANAGISAWA, M ;

LANGLEBEN, D ;

MICHEL, RP ;

LEVY, R ;

SHENNIB, H ;

KIMURA, S ;

MASAKI, T ;

DUGUID, WP ;

STEWART, DJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (24) :1732-1739

← 1 2 →